Inventor · disambiguated record
Michael Christopher Scaife
Also filed as: SCAIFE MICHAEL · SCAIFE MICHAEL C · SCAIFE MICHAEL CHRISTOPHER
18 granted patents·18 pending applications·353 citations·filing 2001–2024
95Inventor score
Top patents by PatentIndex Score
36 records- 0198US8399018B2Controlled release ion channel modulator compositions and methods for the treatment of otic disordersLICHTER JAY·Filed 2009·Granted Mar 19, 2013·49 cites·18 claims
- 0297US8846770B2Controlled release aural pressure modulator compositions and methods for the treatment of OTIC disordersLICHTER JAY·Filed 2009·Granted Sep 30, 2014·33 cites·6 claims
- 0397US8784870B2Controlled release compositions for modulating free-radical induced damage and methods of use thereofLICHTER JAY·Filed 2009·Granted Jul 22, 2014·35 cites·9 claims
- 0497US8496957B2Controlled release auris sensory cell modulator compositions and methods for the treatment of otic disordersLICHTER JAY·Filed 2009·Granted Jul 30, 2013·29 cites·13 claims
- 0596US9132087B2Auris formulations for treating otic diseases and conditionsLICHTER JAY·Filed 2009·Granted Sep 15, 2015·30 cites·6 claims
- 0695US6407128B1Method for increasing the bioavailability of metaxaloneELAN PHARM INC·Filed 2001·Granted Jun 18, 2002·75 cites·22 claims
- 0794US6683102B2Methods of using metaxalone in the treatment of musculoskeletal conditionsELAN PHARM INC·Filed 2002·Granted Jan 27, 2004·53 cites·15 claims
- 0893US7714006B1Methods of modifying the bioavailability of metaxaloneKING PHARMACEUTICALS RES & DEV·Filed 2005·Granted May 11, 2010·17 cites·27 claims
- 0991US10272034B2Auris formulations for treating otic diseases and conditionsOTONOMY INC·Filed 2015·Granted Apr 30, 2019·7 cites·8 claims
- 1089US9333171B2Controlled-release CNS modulating compositions and methods for the treatment of otic disordersOTONOMY INC·Filed 2014·Granted May 10, 2016·7 cites·15 claims
- 1189US2024358634A1Auris formulations for treating otic diseases and conditionsDOMPE FARM SPA·Filed 2024·Application pending·0 cites
- 1286US10232044B2Controlled release aural pressure modulator compositions and methods for the treatment of OTIC disordersOTONOMY INC·Filed 2014·Granted Mar 19, 2019·3 cites·16 claims
- 1386US10092580B2Controlled-release otic structure modulating and innate immune system modulating compositions and methods for the treatment of otic disordersLICHTER JAY·Filed 2009·Granted Oct 9, 2018·8 cites·3 claims
- 1483US8680082B2Controlled release corticosteroid compositions and methods for the treatment of otic disordersLICHTER JAY·Filed 2011·Granted Mar 25, 2014·3 cites·9 claims
- 1582US11241467B2Composition for treating acneSKINTECH LIFE SCIENCE LTD·Filed 2018·Granted Feb 8, 2022·1 cites·17 claims
- 1682US8680083B2Controlled release corticosteroid compositions and methods for the treatment of otic disordersLICHTER JAY·Filed 2011·Granted Mar 25, 2014·3 cites·8 claims
- 1781US2024390326A1Sublingual or buccal administration of dim for treatment of skin diseasesSKINTECH LIFE SCIENCE LTD·Filed 2024·Application pending·0 cites
- 1879US2022040096A1Auris formulations for treating otic diseases and conditionsOTONOMY INC·Filed 2021·Application pending·0 cites
- 1977US10918594B2Controlled-release CNS modulating compositions and methods for the treatment of otic disordersOTONOMY INC·Filed 2019·Granted Feb 16, 2021·0 cites·20 claims
- 2074US2021220263A1Controlled-release cns modulating compositions and methods for the treatment of otic disordersOTONOMY INC·Filed 2021·Application pending·0 cites
- 2172US2010016450A1Controlled release delivery devices for the treatment of otic disordersOTONOMY INC·Filed 2009·Application pending·0 cites
- 2272US2022362212A1Sublingual or buccal administration of dim for treatment of skin diseasesSKINTECH LIFE SCIENCE LTD·Filed 2022·Application pending·0 cites
- 2369US2009325938A1Controlled-release cns modulating compositions and methods for the treatment of otic disordersOTONOMY INC·Filed 2009·Application pending·0 cites
- 2467US11331303B2Sublingual or buccal administration of dim for treatment of skin diseasesSKINTECH LIFE SCIENCE LTD·Filed 2017·Granted May 17, 2022·0 cites·10 claims
- 2567US2022193167A1Combination therapy for treatment of skin diseasesSKINTECH LIFE SCIENCE LTD·Filed 2021·Application pending·0 cites
- 2665US2018110727A1Controlled release corticosteroid compositions and methods for the treatment of otic disordersOTONOMY INC·Filed 2017·Application pending·0 cites
- 2765US2010016218A1Controlled-release apoptosis modulating compositions and methods for the treatment of otic disordersOTONOMY INC·Filed 2009·Application pending·0 cites
- 2863US2019192425A1Controlled release delivery devices for the treatment of otic disordersOTONOMY INC·Filed 2019·Application pending·0 cites
- 2961US2016228357A1Auris Formulations for Treating Otic Diseases and ConditionsOTONOMY INC·Filed 2016·Application pending·0 cites
- 3060US11969501B2Auris formulations for treating otic diseases and conditionsDOMPE FARM SPA·Filed 2021·Granted Apr 30, 2024·0 cites·20 claims
- 3160US2016310415A1Controlled release compositions for modulating free-radical induced damage and methods of use thereofOTONOMY INC·Filed 2016·Application pending·0 cites
- 3259US2017000728A1Controlled-Release CNS Modulating Compositions and Methods for the Treatment of Otic DisordersOTONOMY INC·Filed 2016·Application pending·0 cites
- 3359US2013150410A1Controlled Release Ion Channel Modulator Compositions and Methods for the Treatment of Otic DisordersOTONOMY INC·Filed 2013·Application pending·0 cites
- 3459US2019298799A1Controlled-release apoptosis modulating compositions and methods for the treatment of otic disordersOTONOMY INC·Filed 2019·Application pending·0 cites
- 3550US2016199446A1Controlled-release apoptosis modulating compositions and methods for the treatment of otic disordersOTONOMY INC·Filed 2016·Application pending·0 cites
- 3650US2008275036A1Prevention and treatment of cardiac conditionsAPT PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michael Christopher Scaife files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →